OGHS is First in the State to Offer New Heart Procedure





Opelousas, La, 3/27/14 – Opelousas General Health System and Cardiovascular Institute of the South are among the first in the country and the first in the state of Louisiana to use the Diamondback 360® Coronary Orbital Atherectomy System (OAS) from Cardiovascular Systems, Inc. (CSI). This technology is the first evidence-based, safe treatment approved by FDA for severely calcified coronary lesions. The Diamondback 360® Coronary OAS uses a patented combination of differential sanding and centrifugal force to reduce arterial calcium that can cause complications when treating coronary artery disease (CAD), a life-threatening condition.  Arterial calcium is a common occurrence and can lead to significant complications, with moderate to severe arterial calcium present in nearly 40 percent of patients undergoing a percutaneous coronary intervention in the U.S.


 “Opelousas General Health System and CIS are at the leading edge of innovative cardiac care, and selected the revolutionary technology based on studies of its safety and effectiveness in treating severely calcified coronary lesions,” said Mark Marley, President and CEO. “The Diamondback 360 Coronary OAS provides our patients undergoing percutaneous coronary intervention procedures with the first evidence-based option approved by the FDA for this difficult to treat patient population.”


Dr. Kaylan Veerina and Dr. Robert Menuet, both interventional cardiologists with Cardiovascular Institute of the South, first used the Diamondback 360® Coronary OAS earlier this month.  “ I am thrilled to be one of the first physicians in the country to use this leading edge technology to not only save lives, but to provide quality of life to the patients at Opelousas General,” said Kalyan Veerina.  “It is both astounding and exhilarating to know that we have the remarkable technology of the Diamonback 360® Coronary OAS at our fingertips when most of the country has not yet even heard of it,” said Menuet.


The Diamondback 360® Coronary OAS is an eccentrically mounted 1.25-millimeter diamond-coated crown that sands away calcium in severely calcified coronary arteries, enabling stent deployment. As the crown rotates and orbit increases, centrifugal force presses the crown against the lesion, reducing arterial calcium, while healthy tissue flexes away.

About Coronary Artery Disease

Coronary Artery Disease (CAD) is a life-threatening condition and leading cause of death in men and women in the United States. CAD occurs when a fatty material called plaque builds up on the walls of arteries that supply blood to the heart. The plaque buildup causes the arteries to harden and narrow (atherosclerosis), reducing blood flow. The risk of CAD increases if a person has one or more of the following: high blood pressure, abnormal cholesterol levels, diabetes, or family history of early heart disease. According to the American Heart Association, 16.3 million people in the United States have been diagnosed with CAD. CAD is the most common form of heart disease and claims more than 600,000 lives, or 1 in 4 Americans, in the United States each year. According to estimates, significant arterial calcium is present in nearly 40 percent of patients undergoing a percutaneous coronary intervention (PCI). Significant calcium contributes to poor outcomes and higher treatment costs in coronary interventions when traditional therapies are used, including a significantly higher occurrence of death and MACE.

About Opelousas General Health System:  Since 1957, Opelousas General Health System has been dedicated to the provision of quality health care through its strong commitment and high standards.  Central to the success of OGHS's commitment for excellence is the presence of an outstanding and highly qualified staff of physicians, nurses, technologists and other personnel who provide professional treatment in a caring environment.  Serving as the region's referral medical center, OGHS is a 241-bed, full service medical center, and the area's most comprehensive community health care facility offering a wide range of medical specialties and state-of-the-art technology. Visit us at www.opelousasgeneral.com


About Cardiovascular Systems, Inc.: Cardiovascular Systems, Inc., based in St. Paul, Minn., is a rapidly growing medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Orbital Atherectomy Systems treat calcified plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. To date, nearly 125,000 of CSI’s devices have been sold to leading institutions across the United States. The U.S. FDA granted approval for the use of the Diamondback 360® Coronary Orbital Atherectomy System on October 21, 2013. CSI aims to lead the industry with the Diamondback Revolution, a new movement providing innovative, evidence-based solutions that meet the demand for interventional cardiology treatments. For more information, visit the company’s website at www.csi360.com.


About Cardiovascular Institute of the South

CIS is one of the most respected groups of cardiologists, representing nearly every specialty in heart and circulatory medicine.  With a team of nearly 500 dedicated team members, CIS serves communities throughout Louisiana, as well as national and international patients, at its 14 clinics.  CIS consistently positions itself at the forefront of technology by providing the most up-to-date technology coupled with compassionate care.  This mission has guided the institute for more than 30 years of service to south Louisiana.  For more information about CIS, call 1-800-425-2565 or visit www.cardio.com. 



Back to News Listing